Introduction: There is no available information about the effects of remifentanil labor analgesia on newborns' vital signs in the first hours after delivery. The aim of the study was to assess changes in the heart rate, blood pressure and oxygen saturation during the first 24 h of neonatal life after using remifentanil patient-controlled analgesia (PCA) for labor analgesia.
Material And Methods: Forty-four full-term neonates, 23 from intravenous PCA remifentanil labor anesthesia 0.
Background: There is no information about an effect of pethidine labor analgesia on newborn vital signs in the first hours after the delivery.
Objectives: The aim of the study was to assess changes in heart rate, blood pressure and oxygen saturation during the first 24 hours of life in neonates born after using pethidine for labor analgesia.
Methods: 55 full-term neonates, 34 from intramuscular pethidine labor anesthesia in doses 50-100 mg and 21 born to mothers without any pharmacological form of anesthesia, were studied.
Aim Of The Study: To assess the impact of various forms of intrapartum analgesia on birth condition of the newborn.
Material: The study included 109 newborns, among them 23 from mothers who received intravenous patient-controlled analgesia (PCA) using remifentanil (0.2 microg/kg per dose), 31 infants from mothers treated with PCA epidural anesthesia with fentanyl and 0.
Aims: The aim of study was to assess the impact of intensive diabetic care, defined as target values for fasting glucose of 60-90mg/dl and 1-h postprandial glucose of below 130mg/dl, on neonatal birth weight in relation to risk indicators for fetal macrosomia in women with gestational diabetes mellitus (GDM).
Methods: In women with (N=543) and without GDM (N=1011) age, height, weight, previous GDM, history of macrosomia, family history of type 2 diabetes, parity and weight gain during pregnancy were recorded.
Results: Neonatal birth weight and frequency distribution of macrosomia and infants with small for gestational age did not differ between women with and without GDM.
A case of rhabdomyosarcoma embryonal of the nasopharynx in a 3-year-old girl has been described. Clinical manifestations and initial diagnostic difficulties resulting in delay of proper diagnosis were discussed. Division of RMS, etiology, differentiation of the most often applied clinical sign and modern therapeutic opportunities depending on the location, histopathological type, the disease advancement level and the patient's age were described.
View Article and Find Full Text PDF